ArticleDrug design, development and therapy2019

Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib.

Despoina Pantazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.